Bedrocan is a medical cannabis strain developed in the Netherlands by the company of the same name. Bedrocan BV, one of the leading EU-GMP certified suppliers of pharmaceutical cannabis in Europe. It is in reality the famous Jack Herer, a sativa-dominant hybrid strain created by Sensi Seeds in the 1990s, whose genetics combine Haze, Northern Lights #5, and Shiva Skunk.
Bedrocan is distinguished by a standardized and rigorously controlled cannabinoid composition: 22% of THC and 0.81% CBD. This standardization is at the heart of the approach Bedrocan, which aims to make cannabis a true medicine that meets modern regulatory requirements.
Variety characteristics
| Characteristic | Detail |
|---|---|
| Type | Hybrid (dominant Sativa) |
| Genetics | Jack Herer (Haze × Northern Lights #5 × Shiva Skunk) |
| THC | 22% |
| CBD | 0,8% |
| Main terpenes | Myrcene, Terpinolene, Ocimene |
| Origin | Netherlands |
| Available since | 2003 |
| Certification | EU-GMP (Good Manufacturing Practice) |
Effects and terpenoid profile
Thanks to its sativa heritage, Bedrocan / Jack Herer is associated with effects euphoric, energizing, and cerebral. patients generally describe a stimulating and positive effect, beneficial for daytime activity.
Its terpene profile also plays an important role in its effects:
- The myrcene contributes to analgesic and relaxing properties
- The terpinolene is associated with potentially protective cardiovascular effects
- L’ocimene It has floral notes and is studied for its anti-inflammatory properties.
On an organoleptic level, Bedrocan presents aromas spicy and floral, with characteristic pine and citrus notes of Jack Herer.
Therapeutic indications
Bedrocan is prescribed through the official medical system for the following conditions:
- Spasticity and pain related to multiple sclerosis or a spinal cord injury
- Nausea and vomiting induced by chemotherapy, radiotherapy, or HIV treatments
- Chronic nerve pain
- Tourette's syndrome
- Palliative care of cancer and HIV/AIDS
Availability and distribution channels
Available since 2003 in the Netherlands, Bedrocan is sold exclusively in pharmacies with a prescription. It is distributed in several countries via the Dutch Office of Medicinal Cannabis (OMC). The company has also expanded its production in Denmark to meet growing European demand.
The other varieties in the Bedrocan range
Bedrocan offers a complete range of standardized varieties, adapted to different patient profiles:
| Variety | THC | CBD | Profile |
|---|---|---|---|
| Bedrocan | 22% | 0,8% | High in THC, sativa |
| Bedropuur | 24% | <1% | Very high THC |
| Bedrobinol | 13,5% | <1% | Moderate THC |
| Bedica | 14% | <1% | Moderate THC |
| Bediol | 6,5% | 8% | Balanced THC/CBD |
| Sorrow | 0,4% | 9% | Rich in CBD |
